Ety Apriliana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ety Apriliana has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Alexander Dicky
Fakultas Kedokteran Universitas Lampung
1 shared publication- Andi Setiawan
Department of Chemistry, Faculty of Sciences, Lampung University, Bandar Lampung 35145, Indonesia
1 shared publication - Aspita Laila
Department of Chemistry, Faculty of Sciences, Lampung University, Bandar Lampung 35145, Indonesia
1 shared publication - Fendi Setiawan
Department of Chemistry, Faculty of Sciences, Lampung University, Bandar Lampung 35145, Indonesia
1 shared publication - John Hendri
Department of Chemistry, Faculty of Sciences, Lampung University, Bandar Lampung 35145, Indonesia
1 shared publication - Masayoshi Arai
Graduate School of Pharmaceutical Sciences, The University of Osaka, 1–6 Yamadaoka, Suita, Osaka 565–0871, Japan
1 shared publication
Latest Publications
- Open Access
- 28 March 2023
- Published by MDPI AG in Fermentation
- Vol. 9 (4) , 334
Exploration and Biorefinery Antimicrobial Agent through Solid State Fermentation from Indonesia’s Marine Actinomycetes
This study aimed to obtain novel bioactive compounds derived from actinomycetes associated with marine biota from the coast of Indonesia. Actinomycetes have been identified as a potential source of bioactive compounds through enzymatic fermentation. In order to obtain bioactive compounds from the results of the biorefinery process, cultivation was performed by solid state fermentation (SSF) on shrimp shell waste medium. The inhibitory activity against pathogenic microorganisms was measured based on the optical density of samples from Gorontalo and Buleleng, Bali, Indonesia. Six isolates had a clear zone as an indicator of the chitinase activity of chitinase enzymes. The SSF extract, obtained after 14 days of incubation, was assayed for its antimicrobial activity by the 96-well plate microtiter method. Among the six isolates, isolate 19B19A1 had antibacterial and antifungal activity against Staphylococcus aureus and Malassezia globosa, respectively. DNA analysis indicated that the 19B19A1 isolate was Streptomyces tritolerans 19B19A1 and that its extract contained an alkaloid component that played a role in antimicrobial activity. These results indicate that shrimp shells can be used as a nutrient-rich alternative culture medium for actinomycetes. This study is expected to become a source of information related to biorefinery, especially in the exploration of bioactive compounds produced by actinomycetes.
- 28 March 2023
- Published by MDPI AG in Fermentation
- Vol. 9 (4) , 334
Open AccessExploration and Biorefinery Antimicrobial Agent through Solid State Fermentation from Indonesia’s Marine Actinomycetes
This study aimed to obtain novel bioactive compounds derived from actinomycetes associated with marine biota from the coast of Indonesia. Actinomycetes have been identified as a potential source of bioactive compounds through enzymatic fermentation. In order to obtain bioactive compounds from the results of the biorefinery process, cultivation was performed by solid state fermentation (SSF) on shrimp shell waste medium. The inhibitory activity against pathogenic microorganisms was measured based on the optical density of samples from Gorontalo and Buleleng, Bali, Indonesia. Six isolates had a clear zone as an indicator of the chitinase activity of chitinase enzymes. The SSF extract, obtained after 14 days of incubation, was assayed for its antimicrobial activity by the 96-well plate microtiter method. Among the six isolates, isolate 19B19A1 had antibacterial and antifungal activity against Staphylococcus aureus and Malassezia globosa, respectively. DNA analysis indicated that the 19B19A1 isolate was Streptomyces tritolerans 19B19A1 and that its extract contained an alkaloid component that played a role in antimicrobial activity. These results indicate that shrimp shells can be used as a nutrient-rich alternative culture medium for actinomycetes. This study is expected to become a source of information related to biorefinery, especially in the exploration of bioactive compounds produced by actinomycetes.
- Open Access
- 1 October 2016
- Published by Lembaga Penelitian dan Pengabdian kepada Masyarakat Universitas Lampung in Jurnal Kedokteran Universitas Lampung
- Vol. 1 (2) , 308-312
Efek Pemberian Ekstrak Temulawak (Curcuma Xanthorrhiza Roxb) terhadap Daya Hambat Pertumbuhan Staphylococcus Aureus dan Escherichia Coli secara In Vitro
Prevalensi penyakit infeksi di Indonesia masih tergolong tinggi dan menjadi masalah kesehatan di Indonesia. Salah satu penyebab penyakit infeksi adalah bakteri. Antibiotik adalah terapi yang digunakan untuk melawan bakteri. Ekstrak etanol temulawak (Curcuma xanthorrhiza Roxb) memiliki berbagai manfaat, salah satunya sebagai antimikroba karena kandungan kurkumin dan minyak atsiri dalam temulawak dapat menghambat dan membunuh pertumbuhan bakteri. Penelitian inibertujuan untuk mengetahui efek pemberian ekstrak etanol temulawak terhadap daya hambat pertumbuhan Staphylococcus aureus dan Escherichia coli secara in vitro. Dengan menggunakan metode kirby bauer disk diffusion, ekstrak etanol temulawak dengan konsentrasi 10%, 15%, 20%, 25%, 30%, 40%, 80%, 100%, kontrol negatif (akuades steril)dan kontrol positif (kloramfenikol) ditanam dalam Muller Hinton Agar berisi bakteri, diinkubasi dan diukur zona hambat yang terbentuk. Berdasarkan hasil penelitian diketahui bahwa ekstrak etanol temulawak (Curcuma xanthorrhiza Roxb) memiliki daya hambat terhadap bakteri Staphylococcus aureus dan Escherichia coli pada semua konsentrasi uji. [JK Unila. 2016; 1(2)]Kata kunci: antibakteri, Curcuma, daya hambat, Escherichia coli, Staphylococcus aureus
- 1 October 2016
- Published by Lembaga Penelitian dan Pengabdian kepada Masyarakat Universitas Lampung in Jurnal Kedokteran Universitas Lampung
- Vol. 1 (2) , 308-312
Open AccessEfek Pemberian Ekstrak Temulawak (Curcuma Xanthorrhiza Roxb) terhadap Daya Hambat Pertumbuhan Staphylococcus Aureus dan Escherichia Coli secara In Vitro
Prevalensi penyakit infeksi di Indonesia masih tergolong tinggi dan menjadi masalah kesehatan di Indonesia. Salah satu penyebab penyakit infeksi adalah bakteri. Antibiotik adalah terapi yang digunakan untuk melawan bakteri. Ekstrak etanol temulawak (Curcuma xanthorrhiza Roxb) memiliki berbagai manfaat, salah satunya sebagai antimikroba karena kandungan kurkumin dan minyak atsiri dalam temulawak dapat menghambat dan membunuh pertumbuhan bakteri. Penelitian inibertujuan untuk mengetahui efek pemberian ekstrak etanol temulawak terhadap daya hambat pertumbuhan Staphylococcus aureus dan Escherichia coli secara in vitro. Dengan menggunakan metode kirby bauer disk diffusion, ekstrak etanol temulawak dengan konsentrasi 10%, 15%, 20%, 25%, 30%, 40%, 80%, 100%, kontrol negatif (akuades steril)dan kontrol positif (kloramfenikol) ditanam dalam Muller Hinton Agar berisi bakteri, diinkubasi dan diukur zona hambat yang terbentuk. Berdasarkan hasil penelitian diketahui bahwa ekstrak etanol temulawak (Curcuma xanthorrhiza Roxb) memiliki daya hambat terhadap bakteri Staphylococcus aureus dan Escherichia coli pada semua konsentrasi uji. [JK Unila. 2016; 1(2)]Kata kunci: antibakteri, Curcuma, daya hambat, Escherichia coli, Staphylococcus aureus